Capital Fund Management S.A. bought a new position in agilon health, inc. (NYSE:AGL – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 20,552 shares of the company’s stock, valued at approximately $332,000.
Other hedge funds also recently modified their holdings of the company. Versor Investments LP bought a new stake in agilon health during the fourth quarter worth approximately $399,000. Yarger Wealth Strategies LLC grew its stake in agilon health by 20.5% in the 3rd quarter. Yarger Wealth Strategies LLC now owns 163,877 shares of the company’s stock valued at $3,838,000 after buying an additional 27,876 shares during the last quarter. Quantamental Technologies LLC bought a new position in agilon health in the 3rd quarter worth $223,000. Thrivent Financial for Lutherans lifted its position in agilon health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 871,220 shares of the company’s stock worth $20,404,000 after acquiring an additional 59,901 shares during the last quarter. Finally, Bailard Inc. bought a new stake in agilon health during the fourth quarter valued at about $680,000.
agilon health Trading Up 4.9 %
AGL stock opened at $20.22 on Monday. agilon health, inc. has a 1-year low of $15.00 and a 1-year high of $29.44. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.03. The business’s 50 day moving average is $24.32 and its 200-day moving average is $21.65. The firm has a market cap of $8.39 billion, a P/E ratio of -91.91 and a beta of 1.12.
Insider Activity
In related news, insider Benjamin Kornitzer sold 8,094 shares of the stock in a transaction dated Wednesday, March 8th. The shares were sold at an average price of $24.44, for a total transaction of $197,817.36. Following the completion of the sale, the insider now owns 10,426 shares in the company, valued at approximately $254,811.44. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other agilon health news, insider Benjamin Shaker sold 25,000 shares of the business’s stock in a transaction on Tuesday, April 18th. The stock was sold at an average price of $28.05, for a total value of $701,250.00. Following the transaction, the insider now owns 79,543 shares of the company’s stock, valued at $2,231,181.15. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Benjamin Kornitzer sold 8,094 shares of the stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $24.44, for a total value of $197,817.36. Following the sale, the insider now owns 10,426 shares in the company, valued at approximately $254,811.44. The disclosure for this sale can be found here. In the last quarter, insiders have sold 94,244,992 shares of company stock worth $1,960,666,646. Corporate insiders own 3.60% of the company’s stock.
Analyst Upgrades and Downgrades
AGL has been the topic of several recent analyst reports. Stifel Nicolaus lifted their price target on agilon health from $29.00 to $32.00 in a research report on Wednesday, May 10th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of agilon health from $28.00 to $27.00 in a report on Monday, May 15th. Wells Fargo & Company boosted their price objective on shares of agilon health from $22.00 to $28.00 in a report on Thursday, March 16th. Truist Financial upped their price objective on shares of agilon health from $29.00 to $35.00 and gave the company a “buy” rating in a research report on Monday, April 17th. Finally, Guggenheim lifted their target price on agilon health from $21.00 to $30.00 and gave the stock a “buy” rating in a research report on Monday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $31.13.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
Read More
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Will Nvidia Be the Lifeline Intel Desperately Needs?
- Is Li Auto Head and Shoulders Above Its Chinese Counterparts?
- MarketBeat Week in Review – 5/29 – 6/2
- Trading Channel Breakout in Lululemon Brought by Earnings
- What Should Investors Make of These 3 Dividend Cuts?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.
